Literature DB >> 35260967

Discrepancy between plaque vulnerability and functional severity of angiographically intermediate coronary artery lesions.

Tatsuro Yamazaki1, Takeshi Nishi2,3, Yuichi Saito1, Kazuya Tateishi1, Ken Kato1, Hideki Kitahara1, Yoshio Kobayashi1.   

Abstract

This study sought to investigate the relationship between physiological severity and plaque vulnerability of intermediate coronary artery stenoses as assessed by fractional flow reserve (FFR) and near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS). We included vessels where both FFR and NIRS-IVUS were performed. A positive FFR was defined as FFR ≤ 0.80. Lipid core burden index of the entire target vessel (TV-LCBI), maximum LCBI in 4 mm (maxLCBI4mm), and maximum plaque burden (PB) were evaluated using NIRS-IVUS. A vulnerable plaque was defined as a lipid-rich plaque (maxLCBI4mm ≥ 400) with large PB (≥ 70%). A total of 59 vessels of 45 patients were included. Median FFR value was 0.75 [interquartile 0.72, 0.82]. An FFR value of ≤ 0.80 was observed in 42 vessels (71%). TV-LCBI (correlation coefficient [CC] = - 0.331, p = 0.011), lesion length (CC = - 0.350, p = 0.007), and PB (CC = - 0.230, p = 0.080) negatively correlated with FFR value, while maxLCBI4mm did not (CC = - 0.156, p = 0.24). The prevalence of vulnerable plaques (26.2% vs. 29.4%, p > 0.99) and mean TV-LCBI, maxLCBI4mm, and PB values were not significantly different between the vessels with FFR ≤ 0.80 and those with FFR > 0.80. In multivariable logistic models, diabetes mellitus (p = 0.003) and hemoglobin A1c (p = 0.012) were associated with the presence of a vulnerable plaque. In conclusion, the results of the present study suggested that FFR may reflect total lipid burden but not necessarily plaque vulnerability. In patients with coronary artery disease and a high likelihood of rapid atherosclerosis progression, such as diabetes mellitus patients, assessing plaque vulnerability in addition to the functional severity of coronary artery lesions may help stratify better the risk of future events.
© 2022. The Author(s) under exclusive licence to Japanese Association of Cardiovascular Intervention and Therapeutics.

Entities:  

Keywords:  Fractional flow reserve; Intravascular ultrasound; Near-infrared spectroscopy; Vulnerable plaque

Mesh:

Substances:

Year:  2022        PMID: 35260967     DOI: 10.1007/s12928-022-00851-5

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN: 1868-4297


  3 in total

Review 1.  2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Authors:  Martha Gulati; Phillip D Levy; Debabrata Mukherjee; Ezra Amsterdam; Deepak L Bhatt; Kim K Birtcher; Ron Blankstein; Jack Boyd; Renee P Bullock-Palmer; Theresa Conejo; Deborah B Diercks; Federico Gentile; John P Greenwood; Erik P Hess; Steven M Hollenberg; Wael A Jaber; Hani Jneid; José A Joglar; David A Morrow; Robert E O'Connor; Michael A Ross; Leslee J Shaw
Journal:  Circulation       Date:  2021-10-28       Impact factor: 29.690

2.  Association of microvascular dysfunction with clinical outcomes in patients with non-flow limiting fractional flow reserve after percutaneous coronary intervention.

Authors:  Takeshi Nishi; Tadashi Murai; Katsuhisa Waseda; Atsushi Hirohata; Andy S C Yong; Martin K C Ng; Tetsuya Amano; Emanuele Barbato; Tsunekazu Kakuta; William F Fearon
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.